ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,962Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 2035

$1.27M Total Retail Price of All Prescriptions

Rank: 24 out of 2035

611 Patients Receiving at Least One Drug in Part D
42%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

47% of this provider’s 611 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

45% of this provider’s 611 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 8,533 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
OXYCODONE HCL 1,841 645 S2 1 62
HYDROCODONE-ACETAMINOPHEN 1,585 562 S3 2 2
LISINOPRIL 785 384 3 3
AMLODIPINE BESYLATE 706 353 4 6
SIMVASTATIN 613 280 5 1
PROAIR HFA 584 231 6 31
POTASSIUM CHLORIDE 476 195 7 18
OMEPRAZOLE 471 206 8 5
HYDROCHLOROTHIAZIDE 443 208 9 12
METFORMIN HCL 430 199 10 9
CARISOPRODOL 402 56 R 11 57
METOPROLOL TARTRATE 377 212 12 8
OPANA ER 376 130 S2 13 172
RANITIDINE HCL 355 195 14 28
FUROSEMIDE 337 195 15 7
IBUPROFEN 282 144 16 43
ADVAIR DISKUS 271 119 17 38
CLONIDINE HCL 265 92 18 61
LISINOPRIL-HYDROCHLOROTHIAZIDE 250 106 19 26
ACETAMINOPHEN-CODEINE 237 156 S3 20 52
TRIAMTERENE-HCTZ 231 157 21 35
GLIPIZIDE 226 140 22 54
LIDODERM 185 60 23 72
ZOLPIDEM TARTRATE 182 73 24 21
CLOBETASOL PROPIONATE 178 103 25 288
CEPHALEXIN 176 52 26 91
CLOPIDOGREL 152 59 27 30
CYCLOBENZAPRINE HCL 146 48 R 28 64
NASONEX 142 39 29 207
NEXIUM 136 64 30 51
PLAVIX 135 64 31 49
AZITHROMYCIN 132 46 32 39
LANTUS 129 56 33 40
SURE COMFORT 121 54 34 243
CARVEDILOL 118 83 35 22
LEVOTHYROXINE SODIUM 116 89 36 4
NIFEDIPINE ER 115 86 37 98
GABAPENTIN 108 39 38 14
TAMSULOSIN HCL 106 85 39 25
ATORVASTATIN CALCIUM 106 47 39 13
NOVOLOG 104 37 41 95
ALLOPURINOL 91 41 42 34
DICLOFENAC SODIUM 91 85 42 173
ALCOHOL SWABS 89 55 44 182
INDOMETHACIN 88 62 R 45 280
VENTOLIN HFA 88 39 45 80
HYDRALAZINE HCL 88 36 45 45
LYRICA 87 23 48 89
NAPROXEN 86 46 49 92
AMMONIUM LACTATE 83 37 50 155
CELEBREX 82 53 51 104
BYSTOLIC 81 34 52 108
AMOXICILLIN 80 31 53 116
PROMETHAZINE HCL 79 36 R 54 106
CRESTOR 79 32 54 41
VERAPAMIL ER 76 55 56 115
FLUCONAZOLE 74 0 57 198
ATENOLOL 73 23 58 10
SPIRIVA 71 16 59 44
VOLTAREN 71 55 59 141
ISOSORBIDE MONONITRATE ER 70 45 61 32
FLUTICASONE PROPIONATE 66 26 62 29
ECONAZOLE NITRATE 61 15 63 373
METOPROLOL SUCCINATE 61 31 63 16
ALPRAZOLAM 59 18 65 109
TRAMADOL HCL 58 0 66 19
AMITRIPTYLINE HCL 57 0 R 67 101
PHENYTOIN SODIUM EXTENDED 57 14 67 132
INSULIN SYRINGE 57 13 67 97
LANTUS SOLOSTAR 54 16 70 66
PENTOXIFYLLINE 54 23 70 285
ENALAPRIL MALEATE 54 23 70 60
SYMBICORT 52 32 73 107
NOVOLOG MIX 70-30 51 19 74 254
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 19, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.